Topic: Antiviral Drugs

The discussion shifts to antiviral treatments like Tamiflu and Relenza, which are noted for their effectiveness in stopping flu progression if taken early. It is observed that these treatments are rarely mentioned in mainstream news reports compared to vaccines. The segment also covers the process of how flu strains are selected for vaccines based on data from Australia.

A scathing Inspector General report reveals that the Department of Homeland Security (DHS) mismanaged its pandemic preparedness supplies. The audit found that DHS purchased 16 million surgical masks and 350,000 coverall suits without a clear plan, and many respirators and antiviral drugs have exceeded their shelf life. Additionally, the department failed to track its inventory, leading to missing or improperly stored medications.

Hospitals in Brazil and the U.S. are reportedly being told to use batches of Tamiflu that are one year past their expiration dates. Manufacturers claim stability testing shows the pills remain effective, but some medical professionals are advising patients to request medication within the official validity period.

Reports from patients at Kaiser Permanente suggest that doctors are refusing to issue Tamiflu prescriptions for prophylactic use. Some medical staff have claimed that all Tamiflu distributions must now be cleared through the CDC, though this is suspected to be a cost-saving measure by the healthcare provider rather than a formal federal mandate. The high cost of the antiviral drug is cited as a likely reason for the restricted access.